Sildenafil citrate (VIAGRA®): Overall safety profile in 18 double blind, placebo controlled, clinical trials

International Journal of Clinical Practice, Supplement

Volumn , Issue 102, 1999, Pages 3-5

  Osterloh, I H ^a   Collins, M ^a   Wicker, P ^a   Wagner, G ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; PIPERAZINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPEPSIA; HEADACHE; HEART INFARCTION; HOT FLUSH; HUMAN; HYPOTENSION; MALE; NOSE CONGESTION; PRIORITY JOURNAL; VISUAL DISORDER; ADOLESCENT; CONTROLLED CLINICAL TRIAL; IMPOTENCE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; CONTROLLED CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES;

EID: 0032585796     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)